Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.030
-0.040 (-1.93%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
-0.030 (-1.48%)
After-hours: Dec 5, 2025, 5:49 PM EST
Nautilus Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 23.88 | 27.65 | 19.4 | 114.52 | 185.62 | 36.61 | Upgrade
|
| Short-Term Investments | 107.55 | 102.25 | 154.02 | 69.95 | 160.11 | 40.14 | Upgrade
|
| Cash & Short-Term Investments | 131.43 | 129.89 | 173.42 | 184.47 | 345.73 | 76.74 | Upgrade
|
| Cash Growth | -6.53% | -25.10% | -5.99% | -46.64% | 350.51% | 360.66% | Upgrade
|
| Prepaid Expenses | 2.9 | 2.93 | 3.42 | 2.74 | 3.49 | 0.92 | Upgrade
|
| Total Current Assets | 134.33 | 132.83 | 176.84 | 187.21 | 349.22 | 77.66 | Upgrade
|
| Property, Plant & Equipment | 28.35 | 32.33 | 36.9 | 32.57 | 31.86 | 6.21 | Upgrade
|
| Long-Term Investments | 37.06 | 76.41 | 90.65 | 129.17 | 16.37 | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.21 | Upgrade
|
| Other Long-Term Assets | 1.18 | 1.18 | 1.18 | 1.11 | 1 | 0.93 | Upgrade
|
| Total Assets | 200.92 | 242.74 | 305.57 | 350.05 | 398.45 | 85.01 | Upgrade
|
| Accounts Payable | 0.89 | 0.99 | 1.64 | 1.27 | 1.72 | 0.47 | Upgrade
|
| Accrued Expenses | 3.66 | 2.03 | 3.57 | 3.09 | 2.73 | 0.94 | Upgrade
|
| Current Portion of Leases | 4.21 | 4.1 | 3.54 | 1.99 | 0.97 | 1.48 | Upgrade
|
| Other Current Liabilities | 0.22 | 0.52 | 0.38 | 0.44 | 0.39 | 0.13 | Upgrade
|
| Total Current Liabilities | 8.98 | 7.63 | 9.12 | 6.79 | 5.81 | 3.02 | Upgrade
|
| Long-Term Leases | 22.79 | 26.38 | 31.09 | 28.34 | 29.06 | 3.3 | Upgrade
|
| Total Liabilities | 31.78 | 34.01 | 40.21 | 35.13 | 34.87 | 6.31 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 487.17 | 481.68 | 467.83 | 455.33 | 444.39 | 0.6 | Upgrade
|
| Retained Earnings | -318.24 | -273.02 | -202.24 | -138.56 | -80.64 | -30.33 | Upgrade
|
| Comprehensive Income & Other | 0.2 | 0.06 | -0.26 | -1.85 | -0.18 | 0 | Upgrade
|
| Total Common Equity | 169.14 | 208.73 | 265.35 | 314.92 | 363.58 | -29.72 | Upgrade
|
| Shareholders' Equity | 169.14 | 208.73 | 265.35 | 314.92 | 363.58 | 78.7 | Upgrade
|
| Total Liabilities & Equity | 200.92 | 242.74 | 305.57 | 350.05 | 398.45 | 85.01 | Upgrade
|
| Total Debt | 27 | 30.48 | 34.63 | 30.33 | 30.03 | 4.78 | Upgrade
|
| Net Cash (Debt) | 104.42 | 99.42 | 138.79 | 154.14 | 315.7 | 71.97 | Upgrade
|
| Net Cash Growth | -4.23% | -28.37% | -9.96% | -51.17% | 338.67% | 332.00% | Upgrade
|
| Net Cash Per Share | 0.83 | 0.79 | 1.11 | 1.24 | 3.74 | 2.47 | Upgrade
|
| Filing Date Shares Outstanding | 126.31 | 126.15 | 125.1 | 124.87 | 124.43 | 9.11 | Upgrade
|
| Total Common Shares Outstanding | 126.31 | 126.11 | 125.07 | 124.87 | 124.3 | 9.11 | Upgrade
|
| Working Capital | 125.34 | 125.19 | 167.72 | 180.42 | 343.41 | 74.64 | Upgrade
|
| Book Value Per Share | 1.34 | 1.66 | 2.12 | 2.52 | 2.92 | -3.26 | Upgrade
|
| Tangible Book Value | 169.14 | 208.73 | 265.35 | 314.92 | 363.58 | -29.72 | Upgrade
|
| Tangible Book Value Per Share | 1.34 | 1.66 | 2.12 | 2.52 | 2.92 | -3.26 | Upgrade
|
| Machinery | 9.52 | 9.31 | 7.88 | 5.42 | 4.19 | 2.49 | Upgrade
|
| Construction In Progress | 1.73 | 1.19 | 0.9 | 1.24 | 0.28 | - | Upgrade
|
| Leasehold Improvements | 0.12 | 0.12 | 0.12 | 0.01 | 0.01 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.